Substance

ID:231

Names and Identifiers
IUPAC Traditional name
trimethadione
IUPAC name
trimethyl-1,3-oxazolidine-2,4-dione
Brand Name
TridoneTrimedoneTrimetinTromedoneEpixalMino-AleviatinPetidionTioxanonaTricioneAbsentolEpidoneTridionTridioneTrioxanonaTriozanonaTroxidoneAbsetilEdionEtydionMinoaleuiatinTredioneTrilidonaPitmalPtimalTridilonaTrimedalTrimethinEpidioneMinoaleviatinNeo-AbsentolPetidonPetilepPetimalinConvenixaConvexina
Synonyms
TrimethadionTrimetadioneTrimethdioneTrimethadione
Registration numbers
CAS Number
PubChem CID
PubChem SID
Properties
Physical Property
Hydrophobicity(logP)
0
Solubility
50 g/L
Molecule Details
Drug Groups
approved
Description
An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
Indication
Used in the control of absence (petit mal) seizures that are refractory to treatment with other medications.
Pharmacology
Paramethadione and trimethadione are anticonvulsants indicated in the control of absence (petit mal) seizures that are refractory to treatment with other medications. Dione anticonvulsants are used in the treatment of epilepsy. They act on the central nervous system (CNS) to reduce the number of seizures.
Toxicity
Symptoms of overdose include clumsiness or unsteadiness, coma, dizziness (severe), drowsiness (severe), nausea (severe), and problems with vision.
Affected Organisms
Humans and other mammals
Protein Binding
90%
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data